HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

David H Broide Selected Research

Asthma (Bronchial Asthma)

1/2023Lymphotoxin beta receptor signaling directly controls airway smooth muscle deregulation and asthmatic lung dysfunction.
1/2022Insights into the biology of IL-9 in asthma.
9/2019Genes and Pathways Regulating Decline in Lung Function and Airway Remodeling in Asthma.
1/2019Airway innate lymphoid cells in the induction and regulation of allergy.
1/2018Orosomucoid-like 3 (ORMDL3) upregulates airway smooth muscle proliferation, contraction, and Ca2+ oscillations in asthma.
1/2018Does reduced zona pellucida binding protein 2 (ZPBP2) expression on chromosome 17q21 protect against asthma?
10/2017Rhinovirus Infection of ORMDL3 Transgenic Mice Is Associated with Reduced Rhinovirus Viral Load and Airway Inflammation.
1/2017Cutting Edge: Targeting Epithelial ORMDL3 Increases, Rather than Reduces, Airway Responsiveness and Is Associated with Increased Sphingosine-1-Phosphate.
1/2017Chromosome 17q21 Genes ORMDL3 and GSDMB in Asthma and Immune Diseases.
1/2017Leukotriene C4 Potentiates IL-33-Induced Group 2 Innate Lymphoid Cell Activation and Lung Inflammation.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


David H Broide Research Topics

Disease

49Asthma (Bronchial Asthma)
01/2023 - 03/2004
34Inflammation (Inflammations)
11/2020 - 06/2003
30Airway Remodeling
09/2019 - 02/2004
27Fibrosis (Cirrhosis)
11/2020 - 02/2004
11Eosinophilia
07/2017 - 05/2007
8Respiratory Hypersensitivity
01/2023 - 07/2002
8Eosinophilic Esophagitis
01/2016 - 08/2008
7Pneumonia (Pneumonitis)
01/2017 - 05/2007
7Allergic Rhinitis
01/2016 - 05/2005
7Hypersensitivity (Allergy)
02/2013 - 01/2006
6Hyperplasia
01/2021 - 05/2011
4Chronic Obstructive Pulmonary Disease (COPD)
06/2011 - 11/2007
3Emphysema
12/2010 - 11/2007
2Lung Diseases (Lung Disease)
11/2020 - 06/2011
2Infections
10/2017 - 01/2016
2Hypoxia (Hypoxemia)
01/2017 - 04/2013
1Hypertrophy
01/2021
1Virus Diseases (Viral Diseases)
09/2019
1Rhinosinusitis
01/2019
1Common Variable Immunodeficiency
02/2017
1Polyps
11/2014
1Nasal Polyps (Nasal Polyp)
11/2014

Drug/Important Bio-Agent (IBA)

44AllergensIBA
01/2023 - 06/2003
21CytokinesIBA
01/2023 - 05/2004
16OvalbuminIBA
01/2016 - 06/2003
14CollagenIBA
11/2020 - 02/2004
9Proteins (Proteins, Gene)FDA Link
01/2021 - 05/2005
9Interleukin-13IBA
09/2019 - 02/2008
9Interleukin-5 (Interleukin 5)IBA
01/2019 - 02/2004
9Adrenal Cortex Hormones (Corticosteroids)IBA
01/2016 - 06/2003
9DNA (Deoxyribonucleic Acid)IBA
03/2006 - 07/2002
8SmokeIBA
09/2019 - 04/2007
8AntigensIBA
01/2016 - 08/2006
8Immunoglobulin E (IgE)IBA
01/2015 - 11/2007
6ChemokinesIBA
06/2014 - 12/2004
6Sialic Acid Binding Immunoglobulin-like LectinsIBA
10/2011 - 05/2007
6Transforming Growth Factor beta (TGF-beta)IBA
10/2009 - 02/2004
5Transforming Growth Factors (Transforming Growth Factor)IBA
09/2019 - 05/2004
4Interleukin-4 (Interleukin 4)IBA
01/2019 - 11/2007
4Orosomucoid (Seromucoid)IBA
01/2018 - 10/2012
4Fibronectins (Fibronectin)IBA
01/2016 - 11/2010
4Extracellular Matrix ProteinsIBA
01/2014 - 03/2006
4Chemokine CCL11IBA
01/2014 - 04/2007
4LigandsIBA
11/2010 - 03/2004
3LeukotrienesIBA
09/2019 - 07/2013
3Interleukin-33IBA
09/2019 - 01/2016
3Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
09/2019 - 03/2008
3FollistatinIBA
01/2017 - 10/2015
3Metalloproteases (Metalloproteinases)IBA
01/2016 - 03/2008
3Methacholine Chloride (Methacholine)FDA Link
10/2012 - 05/2004
3Inflammation MediatorsIBA
06/2011 - 03/2008
3NF-kappa B (NF-kB)IBA
08/2010 - 12/2005
3Transforming Growth Factor beta1 (TGF beta 1)IBA
01/2010 - 01/2006
2Interleukin-9 (Interleukin 9)IBA
01/2022 - 06/2013
2Small Interfering RNA (siRNA)IBA
01/2021 - 10/2012
2Peroxidase (Myeloperoxidase)IBA
01/2017 - 06/2011
2leukotriene D4 receptor (cysteinyl leukotriene receptor)IBA
01/2017 - 07/2013
2Transcription Factors (Transcription Factor)IBA
01/2017 - 10/2012
2Thymic Stromal LymphopoietinIBA
01/2016 - 09/2010
2Immunoglobulin G (IgG)IBA
10/2012 - 05/2011
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
08/2011 - 05/2011
2Carbon MonoxideIBA
06/2011 - 11/2007
2Biomarkers (Surrogate Marker)IBA
06/2011 - 11/2007
2EnzymesIBA
06/2011 - 03/2006
2AdiponectinIBA
12/2010 - 01/2009
2Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
09/2010 - 05/2004
2I-kappa B KinaseIBA
08/2010 - 12/2005
2VaccinesIBA
01/2009 - 07/2002
2Matrix Metalloproteinase 9 (Gelatinase B)IBA
03/2008 - 03/2006
1Member 14 Tumor Necrosis Factor ReceptorsIBA
01/2023
1Bromodeoxyuridine (BrdU)IBA
01/2021
1Bleomycin (Blenoxane)FDA LinkGeneric
11/2020
1Member 25 Tumor Necrosis Factor ReceptorsIBA
11/2020
1Indicators and Reagents (Reagents)IBA
11/2020
1Carrier Proteins (Binding Protein)IBA
01/2018
1CalciumIBA
01/2018
12-5A-dependent ribonuclease (RNase L)IBA
10/2017
1Antiviral Agents (Antivirals)IBA
10/2017
1Prostaglandin D2IBA
07/2017
1Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
07/2017
1Intravenous Immunoglobulins (IVIG)FDA Link
02/2017
1Nitric Oxide (Nitrogen Monoxide)FDA Link
01/2017
1Beclin-1IBA
01/2017
12- (4- morpholinyl)- 8- phenyl- 4H- 1- benzopyran- 4- oneIBA
01/2017
1LipidsIBA
01/2017
1Interleukin-6 (Interleukin 6)IBA
01/2017
1Leukotriene C4IBA
01/2017
1Arachidonate 5-Lipoxygenase (5 Lipoxygenase)IBA
11/2016
1ProstaglandinsIBA
01/2016
1OX40 LigandIBA
01/2016
1Plasminogen Activator Inhibitor 1IBA
01/2016
1VimentinIBA
01/2016
1Forkhead Transcription Factors (Forkhead Box Proteins)IBA
01/2016
1Oncostatin MIBA
10/2015
1Cyclic AMP (AMP, Cyclic)IBA
02/2015
1Tryptases (Tryptase)IBA
01/2015
1phospholambanIBA
11/2014
1Heparitin Sulfate (Heparan Sulfate)IBA
06/2014

Therapy/Procedure

12Therapeutics
11/2020 - 05/2005
2Immunotherapy
01/2006 - 05/2005